Sentences with phrase «in ovarian cancer research»

He is co-chair of the NCI Ovarian Cancer Task Force of the Gynecological Cancer Steering Committee, and was a member of the Institute of Medicine's Committee on the State of the Science in Ovarian Cancer Research.

I was honored to receive the Mentor Award from the American Congress of Obstetricians and Gynecologists in 2012 and the Foundation for Women's Cancer's Excellence in Ovarian Cancer Research Prize in 2013.

Not exact matches

Kelly and accomplished master baker and cake decorator Buddy Valastro, from TLC's «Cake Boss,» recently joined forces at a fun event to bake lavishly decorated cakes in support of The Ovarian Cancer Research...

Recent research demonstrates that lactating women have an earlier return to prepregnant weight, 41 delayed resumption of ovulation with increased child spacing,42 - 44 improved bone remineralization postpartum45 with reduction in hip fractures in the postmenopausal period, 46 and reduced risk of ovarian cancer47 and premenopausal breast cancer.48

Research shows that women who have breastfed have lower chances of getting ovarian cancer and breast cancer later in life.

Her work in protein research at Hunter and her grandmother's recent diagnosis of ovarian cancer sparked an interest in cancer biology and immunology, but Rezende is eager to sample other fields.

This discovery is a result of research on the effects of ONA on a preclinical model of epithelial ovarian cancer (EOC) both in vivo and in vitro.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

Cancer researcher Janet Sawicki of the Lankenau Institute for Medical Research in Pennsylvania, chemical engineer Robert Langer of MIT, and their colleagues are investigating biodegradable nanoparticles to deliver gene therapy for ovarian cCancer researcher Janet Sawicki of the Lankenau Institute for Medical Research in Pennsylvania, chemical engineer Robert Langer of MIT, and their colleagues are investigating biodegradable nanoparticles to deliver gene therapy for ovarian cancercancer.

Researchers using data collected by the Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DieOvarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Dieovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Diegcancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Research Annual Meeting in San Diego, CA.

Acknowledging that «this is not a big study, in terms of the overall number of cases, for ovarian cancer it's a very big study,» explains Annekatrin Lukanova of the International Agency for Cancer Research in Lyon, Fcancer it's a very big study,» explains Annekatrin Lukanova of the International Agency for Cancer Research in Lyon, FCancer Research in Lyon, France.

A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer.

Supported by the Basser Research Center for BRCA in Penn's Abramson Cancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related caCancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related cacancer types, including ovarian and breast cancers — the two major BRCA - related cancers.

The lab of co-author Dr. Robert Bast Jr., an expert in ovarian cancer and vice president for translational research at MD Anderson, inserted gel - bound carbon nanotubes into the ovaries of rodents to mimic the accumulations that are expected for nanotubes linked to special antibodies that recognize tumor cells.

Professor Peter Johnson, Cancer Research UK's chief clinician, said: «Although we're making great progress, we still have more to do for people with ovarian cancer, as only one in three patients survive for 10 years or lCancer Research UK's chief clinician, said: «Although we're making great progress, we still have more to do for people with ovarian cancer, as only one in three patients survive for 10 years or lcancer, as only one in three patients survive for 10 years or longer.

«By combining my laboratory's expertise in ovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Meovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medcancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Meovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medcancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MeOvarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MedCancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MedCancer Center at Case Western Reserve University School of Medicine.

The research team with international collaborators analysed more than 100 patient samples from ovarian and other cancer types to discover a distinct population of cells found in some tumours.

Now a team led by Lin Zhang, PhD, research associate professor in the Department of Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, has mined those sequences to identify a non-protein-coding RNA whose expression is linked to ovarian cancer.

Another student who was using phage - display technology to identify new molecular markers in ovarian cancer attended a clinic in gynecologic oncology once a week throughout her dissertation research.

«Dr. Moore's research is ground - breaking in the area of ovarian cancer, and it's all happening in his laboratory in the Knowledge District of Providence.»

Dr. Narod, who is also a Tier 1 Canada Research Chair in Breast Cancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cCancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cancercancer:

Dr James Brenton, Cancer Research UK's ovarian cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save Cancer Research UK's ovarian cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save cancer expert, says: «A blood test to find women at risk of ovarian cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save cancer is an exciting prospect, but this work still needs to be tested in women to see if it can save lives.

Dr. Vasmatzis» research on the «Quantification of Somatic Chromosomal Rearrangements in Circulating Cell - free DNA From Ovarian Cancers» is published in the July 20 edition of Scientific Reports.

«For decades, women have been treated with a combination of treatment options, resulting in poor prognosis for most women with advanced - stage ovarian cancer, but there are many survivors as well,» said Dr. Narod, senior scientist at Women's College Research Institute.

In lab experiments, the research team used cell lines derived from 40 patient tumour samples to identify that CD151 contributes to the survival of cells of high - grade serous ovarian cancer origin.

In their research, scientists at Rutgers created animal models that closely resemble the cancerous tumors found in women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory micIn their research, scientists at Rutgers created animal models that closely resemble the cancerous tumors found in women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratory micin women with ovarian cancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratorycancer by injecting tumor tissues obtained from gynecological cancer patients treated at the Cancer Institute into laboratorycancer patients treated at the Cancer Institute into laboratoryCancer Institute into laboratory mice.

The research was the first to comprehensively examine the six major flavonoid subclasses present in the normal diet with ovarian cancer risk, and the first to investigate the impact of polymers and anthocyanins.

«What we did in this paper is engineer our sensor to be about 15 times better than a previous version, and then compared it against a blood biomarker in a mouse model of ovarian cancer to show that we could beat it,» says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and the senior author of the cancer to show that we could beat it,» says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and the senior author of the Cancer Research and Institute for Medical Engineering and Science, and the senior author of the study.

The collaborative research team — which included experts in gynecological cancer, genomics, pathology and computational biology — performed a comprehensive genetic analysis of ovarian and endometrial CSs.

In earlier research, Barbolina discovered that a fractalkine receptor — a protein found on the cell surface — is expressed in the majority of ovarian cancer caseIn earlier research, Barbolina discovered that a fractalkine receptor — a protein found on the cell surface — is expressed in the majority of ovarian cancer casein the majority of ovarian cancer cases.

Olaparib was licensed in December for women with ovarian cancer and inherited BRCA mutations, but the new research suggests it could also benefit men with genomic faults within their tumours.

The research, «Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo - Osmium Complex in Human Ovarian Cancer Cells», is published in Chemistry — A European Journal.

While previous research had shown some effectiveness of this molecule in a mouse model of ovarian cancer, that benefit was limited by the immunosuppressive environment within tumors, particularly the presence of regulatory T cells (Tregs).

Many of these genes are usually switched off in adults, but previous research has shown that in many cancers — including prostate, ovarian, and brain cancer, melanoma, and leukemia — HOX genes are switched back on, helping the cancer cells to proliferate and survive.

Led by Ludwig Lausanne investigator Alexandre Harari and George Coukos, director of the Ludwig Institute for Cancer Research, Lausanne, the study shows that ovarian tumors harbor highly reactive killer T cells — which kill infected and cancerous cells — and demonstrates how they can be identified and selectively grown for use in personalized, cell - based immunotherapies.

Now, however, a team led by Merajver and another headed by Ellen Solomon and John Trowsdale of the Imperial Cancer Research Fund in London say that they have both found damaged copies of BRCA1 in ovarian tumours from women with no family history of cancer (Nature Genetics, vol 9, p 343 andCancer Research Fund in London say that they have both found damaged copies of BRCA1 in ovarian tumours from women with no family history of cancer (Nature Genetics, vol 9, p 343 andcancer (Nature Genetics, vol 9, p 343 and 439).

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medcancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of MedCancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.

In addition, the study, led by investigators in The Cancer Genome Atlas (TCGA) Research Network, revealed four novel tumor subtypes, while also identifying genomic similarities between endometrial and other cancer types, including breast, ovarian, and colorectal cancerIn addition, the study, led by investigators in The Cancer Genome Atlas (TCGA) Research Network, revealed four novel tumor subtypes, while also identifying genomic similarities between endometrial and other cancer types, including breast, ovarian, and colorectal cancerin The Cancer Genome Atlas (TCGA) Research Network, revealed four novel tumor subtypes, while also identifying genomic similarities between endometrial and other cancer types, including breast, ovarian, and colorectal caCancer Genome Atlas (TCGA) Research Network, revealed four novel tumor subtypes, while also identifying genomic similarities between endometrial and other cancer types, including breast, ovarian, and colorectal cacancer types, including breast, ovarian, and colorectal cancers.

Rieger conducted her research in zebrafish exposed to paclitaxel, a chemotherapeutic agent used for ovarian, breast, lung, pancreatic and other cancers.

After years of breaking ground on nanomaterials for batteries and solar panels, in 2010 she joined MIT's Koch Institute for Integrative Cancer Research and threw herself into solving the riddles of ovarian cCancer Research and threw herself into solving the riddles of ovarian cancercancer.

In addition to the inherited breast and ovarian cancer, her research interests include genetics of hearing loss, the genetic bases of schizophrenia, genetics of systemic lupus erythematosus, and human genetic diversity and evolution.

In the same opening plenary session, George Coukos, M.D, Ph.D., of Ludwig Cancer Research and the University Hospital of Lausanne, discussed some cutting - edge insights into ovarian cancer, a tumor type that's typically resistant to immunothCancer Research and the University Hospital of Lausanne, discussed some cutting - edge insights into ovarian cancer, a tumor type that's typically resistant to immunothcancer, a tumor type that's typically resistant to immunotherapy.

Since 1985, CRI has made more than 75 grants totaling more than $ 21 million in new research and treatment approaches for ovarian cancer.

Research Paper Plectin - targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer Siva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, Anne M. Mills, Michael F. Gutknecht, Alexander L. Klibanov, Jill K. Slack - Davis, Kimberly A. Kelly Theranostics 2018; 8 (10): 2782 - 2798.

An international research team, led by University College London's Professor Jonathan Ledermann, carried out a trial to see whether olaparib could have a role to play in preventing ovarian cancer from coming back in this group of patients.

He is the principal investigator of an NCI - funded, multi-million-dollar Specialized Program of Research Excellence (SPORE) in ovarian cancer, and he is the principal investigator of a multi-million-dollar grant from the New York State Stem Cell Science program (NYSTEM) to pioneer a novel strategy of reprogramming human mature T cells and hematopoietic stem cells for generating sustained attack against ovarian cancer in patients.

A research team led by an award - winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (Mocancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (MoCancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (MoCancer Conference in Liverpool, today (Monday).

Rogan, Canada Research Chair in Genome Bioinformatics, says that 16 to 20 per cent of women in southwestern Ontario, who have their BRCA genes tested for breast and / or ovarian cancer risk, carry disease - causing gene variants that are well - understood by clinicians and genetic counselors.

October 30, 2011 Fat cells in abdomen fuel spread of ovarian cancer A large pad of fat cells that extends from the stomach and covers the intestines provides nutrients that promote the spread and growth of ovarian cancer, reports a research team based at the University of Chicago in the journal Nature Medicine, published online October 30th, 2011.